Effects of the antiparkinsonian drug budipine on central neurotransmitter systems-Reference-Cited by-同舟云学术

Effects of the antiparkinsonian drug budipine on central neurotransmitter systems

Published:1996-04 Issue:1-3 Volume:301 Page:67-73
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Klockgether Thomas,Wüllner Ullrich,Steinbach Joachim Peter,Petersen Vibke,Turski Lechoslaw,Löschmann Peter-Andreas

Publisher

Elsevier BV

Subject

Pharmacology

Reference26 articles.

1. A potential role of nitric oxide (NO) in neurodegenerative diseases?;Eblen;J. Neurol.,1995

2. Milacemide therapy for Parkinson's disease;Giuffra;Mov. Disord.,1993

3. Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists;Honoré;Science,1988

4. Beeinflussung des Parkinson-Tremors durch Budipin;Iizuka;Nervenarzt,1986

5. Effects of the antiparkinsonian drug budipine on neurotransmitter release in central nervous system tissue in vitro;Jackisch;J. Pharmacol. Exp. Ther.,1993

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SCXRD, DFT and molecular docking based structural analyses towards novel 3-piperazin-1-yl-benzo[d]isothiazole and 3-piperidin-4-yl-benzo[d]isoxazoles appended to quinoline as pharmacological agents;Journal of Molecular Structure;2022-01

2. Synthesis of Novel 2,3-Dihydro-5,6-dimethoxy-2-((piperidin-4-yl)methyl) inden-1-one Derivatives as Acetyl Cholinesterase Inhibitors;Current Bioactive Compounds;2020-06-10

3. Idiopathisches Parkinson-Syndrom (IPS);Klinische Neurologie;2020

4. Idiopathisches Parkinson-Syndrom (IPS);Klinische Neurologie;2018

5. Synthesis, Characterization, Crystal, and Molecular Structure Studies of [1-(3,5-Dimethyl-2,3-dihydro-isoxazole-4-sulfonyl)-piperidin-4-yl}-diphenyl-methanol;Molecular Crystals and Liquid Crystals;2015-07-24